- €155.90bn
- €202.32bn
- $62.58bn
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit (updated)
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit
Factbox: US drugmakers turn to China for licensing deals
Corrected: BioNTech to shutter three sites in Germany as no buyers emerge
China's Xi to visit Washington without CEO delegation, sources say
Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi, sources say (updated)
Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
US weighs allowing most pharma licensing deals with China, sources say
All 50 states sign up for Trump's Medicaid most-favored-nation plan (updated)
Brief: Health Canada Authorizes Pfizer And Biontech's Omicron XFG-Adapted Covid-19 Vaccine
Factbox: Pharma sector doubles down on AI to slash costs, timelines
AstraZeneca's breast cancer pill fails in late-stage trial (updated)
Astrazeneca's breast cancer drug fails late-stage trial
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
Novartis India hits record high on retina drugs distribution deal, Pfizer brand acquisition